ArticleBMC public health2016
Potential health gains and health losses in eleven EU countries attainable through feasible prevalences of the life-style related risk factors alcohol, BMI, and smoking: a quantitative health impact assessment.
Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.Tobacco control · 2023Pooled it
- Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes.The Cochrane database of systematic reviews · 2020Pooled it
- National Life Expectancy Lags Behind Benchmark Progress and the Role of Smoking: An International Comparison.European journal of population = Revue europeenne de demographie · 2025Article
- The methodology of quantitative risk assessment studies.Environmental health : a global access science source · 2024Review
- Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070.Nature reviews. Clinical oncology · 2021Review
- The combined impact of smoking, obesity and alcohol on life-expectancy trends in Europe.International journal of epidemiology · 2021Article
- Future life expectancy in Europe taking into account the impact of smoking, obesity, and alcohol.eLife · 2021Article
- A health inequality impact assessment from reduction in overweight and obesity.BMC public health · 2020Article
- Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios.Preventive medicine reports · 2020Article
- Equity impacts of interventions to increase physical activity among older adults: a quantitative health impact assessment.The international journal of behavioral nutrition and physical activity · 2020Article
- Potential impact of reduced tobacco use on life and health expectancies in Belgium.International journal of public health · 2020Article
- Potential gains in health expectancy by improving lifestyle: an application for European regions.Population health metrics · 2019Article
- The future of integrative health and medicine in Saudi Arabia.Integrative medicine research · 2018Review
- Nutritional status and eating disorders among medical students from the Cluj-Napoca University centre.Clujul medical (1957) · 2018Article
- Cross-Cultural Adaptation and Psychometric Properties of the AUDIT and CAGE Questionnaires in Tanzanian Swahili for a Traumatic Brain Injury Population.Alcohol and alcoholism (Oxford, Oxfordshire) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluencing the life-style risk-factors alcohol, body mass index (BMI), and smoking is an European Union (EU) wide objective of public health policy. The population-level health effects of these risk-factors depend on population specific characteristics and are difficult to quantify without dynamic population health models.
methodsFor eleven countries-approx. 80 % of the EU-27 population-we used evidence from the publicly available DYNAMO-HIA data-set. For each country the age- and sex-specific risk-factor prevalence and the incidence, prevalence, and excess mortality of nine chronic diseases are utilized; including the corresponding relative risks linking risk-factor exposure causally to disease incidence and all-cause mortality. Applying the DYNAMO-HIA tool, we dynamically project the country-wise potential health gains and losses using feasible, i.e. observed elsewhere, risk-factor prevalence rates as benchmarks. The effects of the "worst practice", "best practice", and the currently observed risk-factor prevalence on population health are quantified and expected changes in life expectancy, morbidity-free life years, disease cases, and cumulative mortality are reported.
resultsApplying the best practice smoking prevalence yields the largest gains in life expectancy with 0.4 years for males and 0.3 year for females (approx. 332,950 and 274,200 deaths postponed, respectively) while the worst practice smoking prevalence also leads to the largest losses with 0.7 years for males and 0.9 year for females (approx. 609,400 and 710,550 lives lost, respectively). Comparing morbidity-free life years, the best practice smoking prevalence shows the highest gains for males with 0.4 years (342,800 less disease cases), whereas for females the best practice BMI prevalence yields the largest gains with 0.7 years (1,075,200 less disease cases).
conclusionSmoking is still the risk-factor with the largest potential health gains. BMI, however, has comparatively large effects on morbidity. Future research should aim to improve knowledge of how policies can influence and shape individual and aggregated life-style-related risk-factor behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.